<?xml version="1.0" encoding="UTF-8"?>
<akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <act name="PBH">
    <meta>
      <identification source="#ny-legislature">
        <FRBRWork>
          <FRBRthis value="/akn/us-ny/act/pbh/section-3306"/>
          <FRBRuri value="/akn/us-ny/act/pbh/section-3306"/>
          <FRBRdate date="2023-10-06" name="enacted"/>
          <FRBRauthor href="#ny-legislature"/>
          <FRBRcountry value="us-ny"/>
          <FRBRnumber value="3306"/>
          <FRBRname value="PBH"/>
        </FRBRWork>
        <FRBRExpression>
          <FRBRthis value="/akn/us-ny/act/pbh/section-3306/eng@2025-12-31"/>
          <FRBRuri value="/akn/us-ny/act/pbh/section-3306/eng@2025-12-31"/>
          <FRBRdate date="2025-12-31" name="publication"/>
          <FRBRauthor href="#arch"/>
          <FRBRlanguage language="eng"/>
        </FRBRExpression>
        <FRBRManifestation>
          <FRBRthis value="/akn/us-ny/act/pbh/section-3306/eng@2025-12-31/main.xml"/>
          <FRBRuri value="/akn/us-ny/act/pbh/section-3306/eng@2025-12-31/main.xml"/>
          <FRBRdate date="2025-12-31" name="generation"/>
          <FRBRauthor href="#arch"/>
        </FRBRManifestation>
      </identification>
      <references source="#arch">
        <TLCOrganization eId="arch" href="https://cosilico.ai" showAs="Cosilico Arch"/>
        <TLCOrganization eId="ny-legislature" href="https://legislation.nysenate.gov" showAs="New York State Legislature"/>
      </references>
    </meta>
    <body>
      <section eId="sec_3306">
        <num>3306</num>
        <heading>Schedules of controlled substances</heading>
        <subsection eId="sec_3306__subsec_a">
          <num>(a)</num>
          <content>
            <p>Schedule I shall consist of the drugs and other\nsubstances, by whatever official name, common or usual name, chemical\nname, or brand name designated, listed in this section.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_b">
          <num>(b)</num>
          <content>
            <p>Opiates. Unless specifically excepted or unless listed in another\nschedule, any of the following opiates, including their isomers, esters,\nethers, salts, and salts of isomers, esters, and ethers, whenever the\nexistence of such isomers, esters, ethers and salts is possible within\nthe specific chemical designation (for purposes of 3-methylfentanyl\nonly, the term isomer includes the optical and geometric isomers):\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_b__subsec_1">
            <num>(1)</num>
            <content>
              <p>Acetyl-alpha-methylfentanyl\n(N-{1-(-methyl-2-phenethyl) -4-piperidinyl} -N-phenylacetamide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_2">
            <num>(2)</num>
            <content>
              <p>Acetylmethadol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_3">
            <num>(3)</num>
            <content>
              <p>Allylprodine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_4">
            <num>(4)</num>
            <content>
              <p>Alphacetylmethadol (except levo- alphacetylmethadol also known as\nlevo-alpha-acetylmethadol, levomethadylacetate or LAAM).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_5">
            <num>(5)</num>
            <content>
              <p>Alphameprodine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_6">
            <num>(6)</num>
            <content>
              <p>Alphamethadol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_7">
            <num>(7)</num>
            <content>
              <p>Alpha-methylfentanyl (N-{1-(alpha-methyl-beta-phenyl)\nethyl-4-piperidyl} propionanilide; 1-(1-methyl-2-phenylethyl)\n-4-(N-propanilido) piperidine).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_8">
            <num>(8)</num>
            <content>
              <p>Alpha-methylthiofentanyl (N-{1-methyl-2)2-thienyl)\nethyl-4-piperidinyl} -N-phenylpropanamide).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_9">
            <num>(9)</num>
            <content>
              <p>Beta-hydroxyfentanyl\n(N-{1-2 (2-hydroxy-2-phenethyl)- 4-piperidinyl} -N-phenylpropanamide).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_10">
            <num>(10)</num>
            <content>
              <p>Beta-hydroxy-3-methylfentanyl (other name: N-{1-\n(2-hydroxy-2-phenethyl) -3-methyl -4-piperidinyl} -N-phenylpropanamide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_11">
            <num>(11)</num>
            <content>
              <p>Benzethidine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_12">
            <num>(12)</num>
            <content>
              <p>Betacetylmethadol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_13">
            <num>(13)</num>
            <content>
              <p>Betameprodine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_14">
            <num>(14)</num>
            <content>
              <p>Betamethadol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_15">
            <num>(15)</num>
            <content>
              <p>Betaprodine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_16">
            <num>(16)</num>
            <content>
              <p>Clonitazene.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_17">
            <num>(17)</num>
            <content>
              <p>Dextromoramide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_18">
            <num>(18)</num>
            <content>
              <p>Diampromide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_19">
            <num>(19)</num>
            <content>
              <p>Diethylthiambutene.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_20">
            <num>(20)</num>
            <content>
              <p>Difenoxin.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_21">
            <num>(21)</num>
            <content>
              <p>Dimenoxadol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_22">
            <num>(22)</num>
            <content>
              <p>Dimepheptanol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_23">
            <num>(23)</num>
            <content>
              <p>Dimethylthiambutene.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_24">
            <num>(24)</num>
            <content>
              <p>Dioxaphetyl butyrate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_25">
            <num>(25)</num>
            <content>
              <p>Dipipanone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_26">
            <num>(26)</num>
            <content>
              <p>Ethylmethylthiambutene.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_27">
            <num>(27)</num>
            <content>
              <p>Etonitazene.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_28">
            <num>(28)</num>
            <content>
              <p>Etoxeridine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_29">
            <num>(29)</num>
            <content>
              <p>Furethidine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_30">
            <num>(30)</num>
            <content>
              <p>Hydroxypethidine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_31">
            <num>(31)</num>
            <content>
              <p>Ketobemidone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_32">
            <num>(32)</num>
            <content>
              <p>Levomoramide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_33">
            <num>(33)</num>
            <content>
              <p>Levophenacylmorphan.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_34">
            <num>(34)</num>
            <content>
              <p>3-Methylfentanyl (N-{3-methy1-1- (2- phenylethyl -4-piperidyl}\n-N-phenylpropanamide).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_35">
            <num>(35)</num>
            <content>
              <p>3-Methylthiofentanyl (N-{3-methyl-1- (2-thienyl)ethyl\n-4-piperidinyl} -N-phenylpropanamide).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_36">
            <num>(36)</num>
            <content>
              <p>Morpheridine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_37">
            <num>(37)</num>
            <content>
              <p>MPPP (1-methyl -4-phenyl -4-propionoxypiperidine).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_38">
            <num>(38)</num>
            <content>
              <p>Noracymethadol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_39">
            <num>(39)</num>
            <content>
              <p>Norlevorphanol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_40">
            <num>(40)</num>
            <content>
              <p>Normethadone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_41">
            <num>(41)</num>
            <content>
              <p>Norpipanone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_42">
            <num>(42)</num>
            <content>
              <p>Para-fluorofentanyl (N- (4-fluorophenyl) -N-{1- (2-phenethyl)\n-4-piperidinyl} -propanamide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_43">
            <num>(43)</num>
            <content>
              <p>PEPAP (1- (-2-phenethyl) -4-phenyl -4-acetoxypiperidine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_44">
            <num>(44)</num>
            <content>
              <p>Phenadoxone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_45">
            <num>(45)</num>
            <content>
              <p>Phenampromide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_46">
            <num>(46)</num>
            <content>
              <p>Phenomorphan.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_47">
            <num>(47)</num>
            <content>
              <p>Phenoperidine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_48">
            <num>(48)</num>
            <content>
              <p>Piritramide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_49">
            <num>(49)</num>
            <content>
              <p>Proheptazine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_50">
            <num>(50)</num>
            <content>
              <p>Properidine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_51">
            <num>(51)</num>
            <content>
              <p>Propiram.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_52">
            <num>(52)</num>
            <content>
              <p>Racemoramide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_53">
            <num>(53)</num>
            <content>
              <p>Thiofentanyl (N-phenyl-N-{1- (2-thienyl) ethyl -4- piperidinyl}\n-propanamide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_54">
            <num>(54)</num>
            <content>
              <p>Tilidine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_55">
            <num>(55)</num>
            <content>
              <p>Trimeperidine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_56">
            <num>(56)</num>
            <content>
              <p>3,4-dichloro-N-{(1-dimethylamino)cyclohexylmethyl}benzamide.\nSome trade or other names: AH-7921.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_57">
            <num>(57)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide. Some trade or\nother names: Acetyl Fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_58">
            <num>(58)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide. Other name:\nButyryl Fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_59">
            <num>(59)</num>
            <content>
              <p>N-{1-{2-hydroxy-2-(thiophen-2-yl)ethyl}piperidin-4-yl}-N-\nphenylpropionamide. Other name: Beta-Hydroxythiofentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_60">
            <num>(60)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide. Other\nname: Furanyl Fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_61">
            <num>(61)</num>
            <content>
              <p>3,4-Dichloro-N-{2-(dimethylamino)cyclohexyl}-N-methylbenzamide.\nOther name: U-47700.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_62">
            <num>(62)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide. Other names:\nAcryl Fentanyl or Acryloylfentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_63">
            <num>(63)</num>
            <content>
              <p>N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide.\nOther names: 4-fluoroisobutyryl fentanyl, para-fluoroisobutyryl\nfentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_64">
            <num>(64)</num>
            <content>
              <p>N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide.\nOther names: ortho-fluorofentanyl or 2-fluorofentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_65">
            <num>(65)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carbox-\namide. Other name: tetrahydrofuranyl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_66">
            <num>(66)</num>
            <content>
              <p>2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide. Other\nname: methoxyacetyl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_67">
            <num>(67)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide.\nOther name: cyclopropyl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_68">
            <num>(68)</num>
            <content>
              <p>N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide. Other\nname: para-fluorobutyrylfentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_69">
            <num>(69)</num>
            <content>
              <p>N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetam-\nide. Other name: Ocfentanil.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_70">
            <num>(70)</num>
            <content>
              <p>1-cyclohexyl-4-(1,2-diphenylethyl)piperazine. Other name: MT-45.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_71">
            <num>(71)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide.  Other name:\nValeryl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_72">
            <num>(72)</num>
            <content>
              <p>N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide.\nOther name: para-methoxybutyryl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_73">
            <num>(73)</num>
            <content>
              <p>N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide.\nOther name: para-chloroisobutyryl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_74">
            <num>(74)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide.  Other name:\nisobutyryl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_75">
            <num>(75)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide.\nOther name: cyclopentyl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_76">
            <num>(76)</num>
            <content>
              <p>(E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide.  Other\nname: crotonyl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_77">
            <num>(77)</num>
            <content>
              <p>N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)\npropionamide. Other names: 2'-fluoro ortho-fluorofentanyl; 2'-fluoro\n2-fluorofentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_78">
            <num>(78)</num>
            <content>
              <p>N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide.  Other\nnames:  ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_79">
            <num>(79)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N, 3-diphenylpropanamide.  Other\nnames:   beta'-phenyl fentanyl; beta'-phenyl fentanyl; 3-phenylpropanoyl\nfentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_80">
            <num>(80)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide.\nOther names:  thiofuranyl fentanyl; 2-thiofuranyl fentanyl; thiophene\nfentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_81">
            <num>(81)</num>
            <content>
              <p>N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide. Other\nnames: beta-Methyl fentanyl; beta-methyl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_82">
            <num>(82)</num>
            <content>
              <p>N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide. Other\nnames: ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_83">
            <num>(83)</num>
            <content>
              <p>N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide. Other\nname: 4'-methyl acetyl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_84">
            <num>(84)</num>
            <content>
              <p>2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide.\nOther names: ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl\nfentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_85">
            <num>(85)</num>
            <content>
              <p>N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide.\nOther names: para-methylfentanyl; 4-methylfentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_86">
            <num>(86)</num>
            <content>
              <p>N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide. Other names:\nphenyl fentanyl; benzoyl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_87">
            <num>(87)</num>
            <content>
              <p>ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate. Other name:\nFentanyl carbamate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_88">
            <num>(88)</num>
            <content>
              <p>N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide.\nOther name: ortho-fluoroacryl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_89">
            <num>(89)</num>
            <content>
              <p>N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide.\nOther name: ortho-fluoroisobutyryl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_90">
            <num>(90)</num>
            <content>
              <p>N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide.\nOther name: para-fluoro furanyl fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_91">
            <num>(91)</num>
            <content>
              <p>N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)\nethan-1-amine. Other name: Isotonitazene.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_92">
            <num>(92)</num>
            <content>
              <p>1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-\nbenzo{d}imidazol-2-one. Other names: Brorphine; 1-{1-{1-(4-bromophenyl)\nethyl}-4-piperidinyl}-1,3-dihydro-2H-benzimidazol-2-one.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_c">
          <num>(c)</num>
          <content>
            <p>Opium derivatives. Unless specifically excepted or unless listed\nin another schedule, any of the following opium derivatives, its salts,\nisomers, and salts of isomers whenever the existence of such salts,\nisomers, and salts of isomers is possible within the specific chemical\ndesignation:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_c__subsec_1">
            <num>(1)</num>
            <content>
              <p>Acetorphine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_2">
            <num>(2)</num>
            <content>
              <p>Acetyldihydrocodeine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_3">
            <num>(3)</num>
            <content>
              <p>Benzylmorphine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_4">
            <num>(4)</num>
            <content>
              <p>Codeine methylbromide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_5">
            <num>(5)</num>
            <content>
              <p>Codeine-N-oxide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_6">
            <num>(6)</num>
            <content>
              <p>Cyprenorphine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_7">
            <num>(7)</num>
            <content>
              <p>Desomorphine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_8">
            <num>(8)</num>
            <content>
              <p>Dihydromorphine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_9">
            <num>(9)</num>
            <content>
              <p>Drotebanol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_10">
            <num>(10)</num>
            <content>
              <p>Etorphine (except hydrochloride salt).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_11">
            <num>(11)</num>
            <content>
              <p>Heroin.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_12">
            <num>(12)</num>
            <content>
              <p>Hydromorphinol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_13">
            <num>(13)</num>
            <content>
              <p>Methyldesorphine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_14">
            <num>(14)</num>
            <content>
              <p>Methyldihydromorphine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_15">
            <num>(15)</num>
            <content>
              <p>Morphine methylbromide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_16">
            <num>(16)</num>
            <content>
              <p>Morphine methylsulfonate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_17">
            <num>(17)</num>
            <content>
              <p>Morphine-N-oxide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_18">
            <num>(18)</num>
            <content>
              <p>Myrophine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_19">
            <num>(19)</num>
            <content>
              <p>Nicocodeine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_20">
            <num>(20)</num>
            <content>
              <p>Nicomorphine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_21">
            <num>(21)</num>
            <content>
              <p>Normorphine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_22">
            <num>(22)</num>
            <content>
              <p>Pholcodine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_23">
            <num>(23)</num>
            <content>
              <p>Thebacon.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_d">
          <num>(d)</num>
          <content>
            <p>Hallucinogenic substances. Unless specifically excepted or unless\nlisted in another schedule, any material, compound, mixture, or\npreparation, which contains any quantity of the following hallucinogenic\nsubstances, or which contains any of its salts, isomers, and salts of\nisomers whenever the existence of such salts, isomers, and salts of\nisomers is possible within the specific chemical designation (for\npurposes of this paragraph only, the term "isomer" includes the optical,\nposition and geometric isomers):\n(EXPLANATION--Within the following chemical designations, character\n  symbol substitutions were made from the original text:  "@" = Greek\n  alpha, "&amp;" = Greek beta, "'" = prime mark and "/\" = triangle.)\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_d__subsec_1">
            <num>(1)</num>
            <content>
              <p>4-bromo-2, 5-dimethoxy-amphetamine Some trade or other names:\n4-bromo-2, 5-dimethoxy-@-methylphenethylamine; 4-bromo-2, 5-DMA.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_2">
            <num>(2)</num>
            <content>
              <p>2, 5-dimethoxyamphetamine Some trade or other names:\n2, 5-dimethoxy-@-methylphenethylamine; 2, 5-DMA.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_3">
            <num>(3)</num>
            <content>
              <p>4-methoxyamphetamine Some trade or other names:\n4-methoxy-@-methylphenethylamine; paramethoxyamphetamine, PMA.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_4">
            <num>(4)</num>
            <content>
              <p>5-methoxy-3, 4-methylenedioxy - amphetamine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_5">
            <num>(5)</num>
            <content>
              <p>4-methyl-2, 5-dimethoxy-amphetamine Some trade and other names:\n4-methyl-2, 5-dimethoxy-@-methylphenethylamine; "DOM"; and "STP".\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_6">
            <num>(6)</num>
            <content>
              <p>3, 4-methylenedioxy amphetamine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_7">
            <num>(7)</num>
            <content>
              <p>3, 4, 5-trimethoxy amphetamine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_8">
            <num>(8)</num>
            <content>
              <p>Bufotenine Some trade and other names:  3-(&amp;-dimethylaminoethyl)-5\nhydroxindole; 3-(2-dimethylaminoethyl)- 5-indolol;\nN, N-dimethylserotonin; -5-hydroxy-N, N-dimethyltryptamine; mappine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_9">
            <num>(9)</num>
            <content>
              <p>Diethyltryptamine Some trade and other names:\nN, N-diethyltryptamine; DET.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_10">
            <num>(10)</num>
            <content>
              <p>Dimethyltryptamine Some trade or other names: DMT.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_11">
            <num>(11)</num>
            <content>
              <p>Ibogane Some trade and other names: 7-ethyl-6, 6&amp;, 7, 8, 9, 10,\n12, 13-octahydro-2-methoxy-6, 9-methano-5h-pyrido {1',2':1,2} azepino\n{5,4-b} indole: tabernanthe iboga.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_12">
            <num>(12)</num>
            <content>
              <p>Lysergic acid diethylamide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_13">
            <num>(13)</num>
            <content>
              <p>Mescaline.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_14">
            <num>(14)</num>
            <content>
              <p>Parahexyl. Some trade or other names: 3-Hexyl-1-hydroxy-\n7,8,9,10-tetra hydro-6,6,9-trimethyl-6H-dibenfo{b,d} pyran.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_15">
            <num>(15)</num>
            <content>
              <p>Peyote. Meaning all parts of the plant presently classified\nbotanically as Lophophora williamsii Lemaire, whether growing or not,\nthe seeds thereof, any extract from any part of such plant, and every\ncompound, manufacture, salts, derivative, mixture, or preparation of\nsuch plant, its seeds or extracts.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_16">
            <num>(16)</num>
            <content>
              <p>N-ethyl-3-piperidyl benzilate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_17">
            <num>(17)</num>
            <content>
              <p>N-methyl-3-piperidyl benzilate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_18">
            <num>(18)</num>
            <content>
              <p>Psilocybin.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_19">
            <num>(19)</num>
            <content>
              <p>Psilocyn.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_20">
            <num>(20)</num>
            <content>
              <p>Tetrahydrocannabinols. Synthetic tetrahydrocannabinols not\nderived from the cannabis plant that are equivalents of the substances\ncontained in the plant, or in the resinous extractives of cannabis, sp.\nand/or synthetic substances, derivatives, and their isomers with similar\nchemical structure and pharmacological activity such as the following:\n  delta 1 cis or trans tetrahydrocannabinol, and their optical isomers\n  delta 6 cis or trans tetrahydrocannabinol, and their optical isomers\n  delta 3, 4 cis or trans tetrahydrocannabinol, and its optical isomers\n(since nomenclature of these substances is not internationally\nstandardized, compounds of these structures, regardless of numerical\ndesignation of atomic positions covered). Any Federal Food and Drug\nAdministration approved product containing tetrahydrocannabinol shall\nnot be considered a synthetic tetrahydrocannabinol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_21">
            <num>(21)</num>
            <content>
              <p>Ethylamine analog of phencyclidine. Some trade or other names:\nN-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine,\nN-(1-phenylcyclohexyl) ethylamine cyclohexamine, PCE.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_22">
            <num>(22)</num>
            <content>
              <p>Pyrrolidine analog of phencyclidine. Some trade or other names\n1-(1-phenylcyclohexyl)-pyrrolidine; PCPy, PHP.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_23">
            <num>(23)</num>
            <content>
              <p>Thiophene analog of phencyclidine. Some trade or other names:\n1-{1-(2-thienyl)-cyclohexyl}-piperidine, 2-thienylanalog of\nphencyclidine, TPCP, TCP.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_24">
            <num>(24)</num>
            <content>
              <p>3,4-methylenedioxymethamphetamine (MDMA).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_25">
            <num>(25)</num>
            <content>
              <p>3,4-methylendioxy-N-ethylamphetamine (also known as\nN-ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA,\nMDE, MDEA.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_26">
            <num>(26)</num>
            <content>
              <p>N-hydroxy-3,4-methylenedioxyamphetamine (also known as\nN-hydroxy-alpha-methyl-3,4 (methylenedioxy) phenethylamine, and\nN-hydroxy MDA.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_27">
            <num>(27)</num>
            <content>
              <p>1-{1- (2-thienyl) cyclohexyl} pyrrolidine. Some other names:\nTCPY.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_28">
            <num>(28)</num>
            <content>
              <p>Alpha-ethyltryptamine. Some trade or other names: etryptamine;\nMonase; Alpha-ethyl-1H-indole-3-ethanamine; 3- (2-aminobutyl) indole;\nAlpha-ET or AET.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_29">
            <num>(29)</num>
            <content>
              <p>2,5-dimethoxy-4-ethylamphetamine. Some trade or other names:\nDOET.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_30">
            <num>(30)</num>
            <content>
              <p>4-Bromo-2,5-dimethoxyphenethylamine. Some trade or other names:\n2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB;\n2C-B, Nexus.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_31">
            <num>(31)</num>
            <content>
              <p>2,5-dimethoxy-4-</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_n">
          <num>(n)</num>
          <content>
            <p>-propylthiophenethylamine (2C-T-7), its\noptical isomers, salts and salts of isomers.\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_n__subsec_33">
            <num>(33)</num>
            <content>
              <p>2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,\nalso known as 25I-NBOMe; 2C-I-NBOMe; 25I; or Cimbi-5.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_n__subsec_34">
            <num>(34)</num>
            <content>
              <p>2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,\nalso known as 25 CNBOMe; 2C-C-NBOMe; 25C; or Cimbi-82.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_n__subsec_35">
            <num>(35)</num>
            <content>
              <p>2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,\nalso known as, 25 BNBOMe; 2C-B-NBOMe; Cimbi-36.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_n__subsec_36">
            <num>(36)</num>
            <content>
              <p>5-methoxy-N,N-dimethyltryptamine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_n__subsec_37">
            <num>(37)</num>
            <content>
              <p>Alpha-methyltryptamine. Some trade or other names: AMT.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_n__subsec_38">
            <num>(38)</num>
            <content>
              <p>5-methoxy-N,N-diisopropyltryptamine. Some trade or other names:\n5-MeO-DIPT.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_e">
          <num>(e)</num>
          <content>
            <p>Depressants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a depressant\neffect on the central nervous system, including its salts, isomers, and\nsalts of isomers whenever the existence of such salts, isomers, and\nsalts of isomers is possible within the specific chemical designation:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_e__subsec_1">
            <num>(1)</num>
            <content>
              <p>Mecloqualone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_2">
            <num>(2)</num>
            <content>
              <p>Methaqualone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_3">
            <num>(3)</num>
            <content>
              <p>Phencyclidine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_4">
            <num>(4)</num>
            <content>
              <p>Gamma hydroxybutyric acid, and salt, hydroxybutyric compound,\nderivative or preparation of gamma hydroxybutyric acid, including any\nisomers, esters and ethers and salts of isomers, esters and ethers of\ngamma hydroxybutyric acid, except gamma-butyrolactone, whenever the\nexistence of such isomers, esters and ethers and salts is possible\nwithin the specific chemical.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_5">
            <num>(5)</num>
            <content>
              <p>Gamma-butyrolactone, including butyrolactone; butyrolactone gamma;\n4-butyrolactone; 2(3H)-furanone dihydro; dihydro-2(3H)-furanone;\ntetrahydro-2-furanone; 1,2-butanolide; 1,4-butanolide; 4-butanolide;\ngamma-hydroxybutyric acid lactone; 3-hydroxybutyric acid lactone and\n4-hydroxybutanoic acid lactone with Chemical Abstract Service number\n(96-48-0) when any such substance is intended for human consumption.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_6">
            <num>(6)</num>
            <content>
              <p>1,4 butanediol, including butanediol; butane-1,4-diol;\n1,4-butylene glyco; butylene glycol; 1,4-dihydroxybutane;\n1,4-tetramethylene glycol; tetramethylene glycol; tetramethylene\nAbstract Service number (110-63-4) when any such substance is intended\nfor human consumption.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_f">
          <num>(f)</num>
          <content>
            <p>Stimulants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a stimulant\neffect on the central nervous system, including its salts, isomers, and\nsalts of isomers:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_f__subsec_1">
            <num>(1)</num>
            <content>
              <p>Fenethylline.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_2">
            <num>(2)</num>
            <content>
              <p>N-ethylamphetamine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_3">
            <num>(3)</num>
            <content>
              <p>(+ -)cis-4-methylaminorex ((+ -)cis-4,5-dihydro-4-methyl -5-phenyl\n-2-oxazolamine).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_4">
            <num>(4)</num>
            <content>
              <p>N,N-dimethylamphetamine (also known as N,N-alpha-\ntrimethyl-benzeneethanamine; N,N-alpha- trimethylphenethylamine).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_5">
            <num>(5)</num>
            <content>
              <p>Methcathinone (some other names: 2-(methylamino) - propiophenone;\nalpha-(methylamino) propiophenone; 2-(methylamino) -1-phenylpropan-\n1-one; alpha-N- methylaminopropiophenone; monomethylpropion; ephedrone,\nN-methylcathinone, methylcathinone; AL-464; AL-422; AL-463 and UR1432),\nits salts, optical isomers and salts of optical isomers.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_6">
            <num>(6)</num>
            <content>
              <p>Aminorex. Some other names: aminoxaphen; 2-amino-5-phenyl\n-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_7">
            <num>(7)</num>
            <content>
              <p>Cathinone. Some trade or other names:\n2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone,\n2-aminopropiophenone, and norephedrone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_8">
            <num>(8)</num>
            <content>
              <p>N-benzylpiperazine (some other names: BZP; 1-benzylpiperazine),\nits optical isomers, salts and salts of isomers.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_9">
            <num>(9)</num>
            <content>
              <p>4-methyl-N-methylcathinone or 4-Methylmethcathinone, also known as\nMephedrone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_10">
            <num>(10)</num>
            <content>
              <p>3,4-methylenedioxypyrovalerone or Methylenedioxypyrovalerone,\nalso known as MDPV.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_11">
            <num>(11)</num>
            <content>
              <p>3,4-methylenedioxy-N-methylcathinone (some other names:\nmethylone).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_12">
            <num>(12)</num>
            <content>
              <p>4-Methoxymethcathinone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_13">
            <num>(13)</num>
            <content>
              <p>3-Fluoromethcathinone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_14">
            <num>(14)</num>
            <content>
              <p>4-Fluoromethcathinone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_15">
            <num>(15)</num>
            <content>
              <p>Ethylpropion (Ethcathinone).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_16">
            <num>(16)</num>
            <content>
              <p>2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_17">
            <num>(17)</num>
            <content>
              <p>2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_18">
            <num>(18)</num>
            <content>
              <p>2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_19">
            <num>(19)</num>
            <content>
              <p>2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_20">
            <num>(20)</num>
            <content>
              <p>2-{4-(Ethylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-2).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_21">
            <num>(21)</num>
            <content>
              <p>2-{4-(Isopropylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-4).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_22">
            <num>(22)</num>
            <content>
              <p>2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_23">
            <num>(23)</num>
            <content>
              <p>2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_24">
            <num>(24)</num>
            <content>
              <p>2-(2,5-Dimethoxy-4-</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_n">
          <num>(n)</num>
          <content>
            <p>-propylphenyl)ethanamine (2C-P).\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_g">
          <num>(g)</num>
          <content>
            <p>Synthetic cannabinoids. Unless specifically excepted or unless\nlisted in another schedule, any material, compound, mixture, or\npreparation, which contains any quantity of the following synthetic\ncannabinoid substances, or which contains any of its salts, isomers, and\nsalts of isomers whenever the existence of such salts, isomers, and\nsalts of isomers is possible within the specific chemical designation\n(for purposes of this paragraph only, the term "isomer" includes the\noptical, position and geometric isomers):\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_g__subsec_1">
            <num>(1)</num>
            <content>
              <p>(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)\nmethanone.  Some trade or other names: UR-144.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_g__subsec_2">
            <num>(2)</num>
            <content>
              <p>{1-(5-fluro-pentyl)-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)\nmethanone. Some trade names or other names: 5-fluoro-UR-144, XLR11.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_g__subsec_3">
            <num>(3)</num>
            <content>
              <p>N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide. Some trade or\nother names: APINACA, AKB48.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_g__subsec_4">
            <num>(4)</num>
            <content>
              <p>quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate. Some trade or\nother names: PB-22; QUPIC.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_g__subsec_5">
            <num>(5)</num>
            <content>
              <p>quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. Some\ntrade or other names: 5-fluoro-PB-22; 5F-PB-22.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_g__subsec_6">
            <num>(6)</num>
            <content>
              <p>N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazo-\nle-3-carboxamide. Some trade or other names: AB-FUBINACA.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_g__subsec_7">
            <num>(7)</num>
            <content>
              <p>N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-\ncarboxamide. Some trade or other names: ADB-PINACA.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_g__subsec_8">
            <num>(8)</num>
            <content>
              <p>N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-\nindazole-3-carboxamide. Some trade or other names: AB-CHMINACA.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_g__subsec_9">
            <num>(9)</num>
            <content>
              <p>N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-\ncarboxamide. Some trade or other names: AB-PINACA.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_g__subsec_10">
            <num>(10)</num>
            <content>
              <p>{1-(5-fluoropentyl)-1H-indazol-3-yl}(naphthalen-1-y1)methanone.\nSome trade or other names: THJ-2201.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_h">
          <num>(h)</num>
          <paragraph eId="sec_3306__subsec_h__subsec_1">
            <num>(1)</num>
            <content>
              <p>Cannabimimetic agents. Unless specifically exempted or unless\nlisted in another schedule, any material, compound, mixture, or\npreparation that is not approved by the federal food and drug\nadministration (FDA) which contains any quantity of cannabimimetic\nagents, or which contains their salts, isomers, and salts of isomers\nwhenever the existence of such salts, isomers, and salts of isomers is\npossible within the specific chemical designation.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_2">
            <num>(2)</num>
            <content>
              <p>As used in this subdivision, the term "cannabimimetic agents"\nmeans any substance that is a cannabinoid receptor type 1 (CB1 receptor)\nagonist as demonstrated by binding studies and functional assays within\nany of the following structural classes:\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_i">
          <num>(i)</num>
          <content>
            <p>2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position\nof the phenolic ring by alkyl or alkenyl, whether or not substituted on\nthe cyclohexyl ring to any extent.\n  (ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by\nsubstitution at the nitrogen atom of the indole ring, whether or not\nfurther substituted on the indole ring to any extent, whether or not\nsubstituted on the naphthoyl or naphthyl ring to any extent.\n  (iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of\nthe pyrrole ring, whether or not further substituted in the pyrrole ring\nto any extent, whether or not substituted on the naphthoyl ring to any\nextent.\n  (iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position\nof the indene ring, whether or not further substituted in the indene\nring to any extent, whether or not substituted on the naphthyl ring to\nany extent.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_v">
          <num>(v)</num>
          <content>
            <p>3-phenylacetylindole or 3-benzoylindole by substitution at the\nnitrogen atom of the indole ring, whether or not further substituted in\nthe indole ring to any extent, whether or not substituted on the phenyl\nring to any extent.\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_v__subsec_3">
            <num>(3)</num>
            <content>
              <p>Such term includes:\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_i">
          <num>(i)</num>
          <content>
            <p>5-(1,1-dimethylheptyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol\n(CP-47,497);\n  (ii) 5-(1,1-dimethyloctyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol\n(cannabicyclohexanol or CP-47,497 C8-homolog);\n  (iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);\n  (iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_v">
          <num>(v)</num>
          <content>
            <p>1-hexyl-3-(1-naphthoyl)indole (JWH-019);\n  (vi) 1-{2-(4-morpholinyl)ethyl}-3-(1-naphthoyl)indole (JWH-200);\n  (vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);\n  (viii) 1-pentyl-3-{1-(4-methoxynaphthoyl)}indole (JWH-081);\n  (ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_x">
          <num>(x)</num>
          <content>
            <p>1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);\n  (xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);\n  (xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);\n  (xiii) 1-pentyl-3-{(4-methoxy)-benzoyl}indole (SR-19 and RCS-4);\n  (xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and\nRCS-8); and\n  (xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).\n  Schedule II.</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_a">
          <num>(a)</num>
          <content>
            <p>Schedule II shall consist of the drugs and other\nsubstances, by whatever official name, common or usual name, chemical\nname, or brand name designated, listed in this section.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_b">
          <num>(b)</num>
          <content>
            <p>Substances, vegetable origin or chemical synthesis. Unless\nspecifically excepted or unless listed in another schedule, any of the\nfollowing substances whether produced directly or indirectly by\nextraction from substances of vegetable origin, or independently by\nmeans of chemical synthesis, or by a combination of extraction and\nchemical synthesis:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_b__subsec_1">
            <num>(1)</num>
            <content>
              <p>Opium and opiate, and any salt, compound, derivative, or\npreparation of opium or opiate, excluding apomorphine, dextrorphan,\nnalbuphine, nalmefene, naloxone, and naltrexone, and their respective\nsalts, but including the following:\n  1. Raw opium.\n  2. Opium extracts.\n  3. Opium fluid.\n  4. Powdered opium.\n  5. Granulated opium.\n  6. Tincture of opium.\n  7. Codeine.\n  8. Ethylmorphine.\n  9. Etorphine hydrochloride.\n  10. Hydrocodone (also known as dihydrocodeinone).\n  11. Hydromorphone.\n  12. Metopon.\n  13. Morphine.\n  14. Oxycodone.\n  15. Oxymorphone.\n  16. Thebaine.\n  17. Dihydroetorphine.\n  18. Oripavine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_2">
            <num>(2)</num>
            <content>
              <p>Any salt, compound, derivative, or preparation thereof which is\nchemically equivalent or identical with any of the substances referred\nto in this section, except that these substances shall not include the\nisoquinoline alkaloids of opium.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_3">
            <num>(3)</num>
            <content>
              <p>Opium poppy and poppy straw.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_4">
            <num>(4)</num>
            <content>
              <p>Coca leaves and any salt, compound, derivative, or preparation of\ncoca leaves, and any salt, compound, derivative, or preparation thereof\nwhich is chemically equivalent or identical with any of these substances\nincluding cocaine and ecgonine, their salts, isomers, and salts of\nisomers, except that the substances shall not include: (A) decocainized\ncoca leaves or extraction of coca leaves, which extractions do not\ncontain cocaine or ecgonine; or (B) {123I} ioflupane.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_5">
            <num>(5)</num>
            <content>
              <p>Concentrate of poppy straw (the crude extract of poppy straw in\neither liquid, solid or powder form which contains the phenanthrene\nalkaloids of the opium poppy).\n  (b-1) Unless specifically excepted or unless listed in another\nschedule, any material, compound, mixture, or preparation containing any\nof the following, or their salts calculated as the free anhydrous base\nor alkaloid, in limited quantities as set forth below:\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_1">
            <num>(1)</num>
            <content>
              <p>Not more than three hundred milligrams of dihydrocodeinone\n(hydrocodone) per one hundred milliliters or not more than fifteen\nmilligrams per dosage unit, with a fourfold or greater quantity of an\nisoquinoline alkaloid of opium.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_2">
            <num>(2)</num>
            <content>
              <p>Not more than three hundred milligrams of dihydrocodeinone\n(hydrocodone) per one hundred milliliters or not more than fifteen\nmilligrams per dosage unit, with one or more active nonnarcotic\ningredients in recognized therapeutic amounts.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_c">
          <num>(c)</num>
          <content>
            <p>Opiates. Unless specifically excepted or unless in another\nschedule any of the following opiates, including its isomers, esters,\nethers, salts and salts of isomers, esters and ethers whenever the\nexistence of such isomers, esters, ethers, and salts is possible within\nthe specific chemical designation, dextrorphan and levopropoxyphene\nexcepted:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_c__subsec_1">
            <num>(1)</num>
            <content>
              <p>Alfentanil.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_2">
            <num>(2)</num>
            <content>
              <p>Alphaprodine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_3">
            <num>(3)</num>
            <content>
              <p>Anileridine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_4">
            <num>(4)</num>
            <content>
              <p>Bezitramide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_5">
            <num>(5)</num>
            <content>
              <p>Bulk dextropropoxyphene (non-dosage forms).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_6">
            <num>(6)</num>
            <content>
              <p>Carfentanil.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_7">
            <num>(7)</num>
            <content>
              <p>Dihydrocodeine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_8">
            <num>(8)</num>
            <content>
              <p>Diphenoxylate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_9">
            <num>(9)</num>
            <content>
              <p>Fentanyl.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_10">
            <num>(10)</num>
            <content>
              <p>Isomethadone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_11">
            <num>(11)</num>
            <content>
              <p>Levo-alphacetylmethadol (also known as levo-alpha-acetylmethadol,\nlevomethadylacetate or LAAM).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_12">
            <num>(12)</num>
            <content>
              <p>Levomethorphan.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_13">
            <num>(13)</num>
            <content>
              <p>Levorphanol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_14">
            <num>(14)</num>
            <content>
              <p>Metazocine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_15">
            <num>(15)</num>
            <content>
              <p>Methadone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_16">
            <num>(16)</num>
            <content>
              <p>Methadone-intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl\nbutane.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_17">
            <num>(17)</num>
            <content>
              <p>Moramide-intermediate, 2-methyl-3-morpholino-1,\n1--diphenylpropane--carboxylic acid.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_18">
            <num>(18)</num>
            <content>
              <p>Pethidine (meperidine).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_19">
            <num>(19)</num>
            <content>
              <p>Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_20">
            <num>(20)</num>
            <content>
              <p>Pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_21">
            <num>(21)</num>
            <content>
              <p>Pethidine-intermediate-C, 1--methyl--4-- phenylpiperidine--4--\ncarboxylic acid.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_22">
            <num>(22)</num>
            <content>
              <p>Phenazocine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_23">
            <num>(23)</num>
            <content>
              <p>Piminodine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_24">
            <num>(24)</num>
            <content>
              <p>Racemethorphan.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_25">
            <num>(25)</num>
            <content>
              <p>Racemorphan.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_26">
            <num>(26)</num>
            <content>
              <p>Sufentanil.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_27">
            <num>(27)</num>
            <content>
              <p>Remifentanil.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_28">
            <num>(28)</num>
            <content>
              <p>Tapentadol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_29">
            <num>(29)</num>
            <content>
              <p>Thiafentanil.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_d">
          <num>(d)</num>
          <content>
            <p>Stimulants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a stimulant\neffect on the central nervous system, including its salts, isomers, and\nsalts of isomers:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_d__subsec_1">
            <num>(1)</num>
            <content>
              <p>Amphetamine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_2">
            <num>(2)</num>
            <content>
              <p>Methamphetamine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_3">
            <num>(3)</num>
            <content>
              <p>Phenmetrazine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_4">
            <num>(4)</num>
            <content>
              <p>Methylphenidate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_5">
            <num>(5)</num>
            <content>
              <p>Lisdexamfetamine.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_e">
          <num>(e)</num>
          <content>
            <p>Depressants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a depressant\neffect on the central nervous system, including its salts, isomers, and\nsalts of isomers whenever the existence of such salts, isomers, and\nsalts of isomers is possible within the specific chemical designation:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_e__subsec_1">
            <num>(1)</num>
            <content>
              <p>Amobarbital.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_2">
            <num>(2)</num>
            <content>
              <p>Glutethimide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_3">
            <num>(3)</num>
            <content>
              <p>Pentobarbital.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_4">
            <num>(4)</num>
            <content>
              <p>Secobarbital.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_f">
          <num>(f)</num>
          <content>
            <p>Hallucinogenic substances.\n  Nabilone: Another name for nabilone: (+,-)-trans\n-3-(1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy-6,\n6-dimethyl-9H-dibenzo{b,d}pyran-9-one.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_g">
          <num>(g)</num>
          <content>
            <p>Immediate precursors. Unless specifically excepted or unless\nlisted in another schedule, any material, compound, mixture or\npreparation which contains any quantity of the following substances:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_g__subsec_1">
            <num>(1)</num>
            <content>
              <p>Immediate precursor to amphetamine and methamphetamine:\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_i">
          <num>(i)</num>
          <content>
            <p>Phenylacetone Some trade or other names: pheny1-2-propanone; P2P;\nbenzyl methyl ketone; methyl benzyl ketone;\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_i__subsec_2">
            <num>(2)</num>
            <content>
              <p>Immediate precursors to phencyclidine (PCP):\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_i">
          <num>(i)</num>
          <content>
            <p>1-phenylcyclohexylamine;\n  (ii) 1-piperidinocyclohexanecarbonitrile (PCC).\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_i__subsec_3">
            <num>(3)</num>
            <content>
              <p>Immediate precursor to fentanyl:\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_i">
          <num>(i)</num>
          <content>
            <p>4-anilino-N-phenenethylpiperidine (ANPP).\n  (ii) N-phenyl-N-(piperidin-4-yl)propionamide (Norfentanyl).\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_h">
          <num>(h)</num>
          <content>
            <p>Anabolic steroids. Unless specifically excepted or unless listed\nin another schedule, "anabolic steroid" shall mean any drug or hormonal\nsubstance, chemically and pharmacologically related to testosterone\n(other than estrogens, progestins, corticosteroids and\ndehydroepiandrosterone) and includes:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_h__subsec_1">
            <num>(1)</num>
            <content>
              <p>3{beta}, 17-dihydroxy-5a-androstane.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_2">
            <num>(2)</num>
            <content>
              <p>3{alpha}, 17{beta}-dihydroxy-5a-androstane.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_3">
            <num>(3)</num>
            <content>
              <p>5{alpha}-androstan-3,17-dione.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_4">
            <num>(4)</num>
            <content>
              <p>1-androstenediol (3{beta},17{beta}-dihydroxy-5{alpha}-androst-1-\nene).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_5">
            <num>(5)</num>
            <content>
              <p>1-androstenediol (3{alpha},17{beta}-dihydroxy-5{alpha}-androst-1-\nene).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_6">
            <num>(6)</num>
            <content>
              <p>4-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-4-ene).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_7">
            <num>(7)</num>
            <content>
              <p>5-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-5-ene).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_8">
            <num>(8)</num>
            <content>
              <p>1-androstenedione ({5{alpha}}-androst-1-en-3,17-dione).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_9">
            <num>(9)</num>
            <content>
              <p>4-androstenedione (androst-4-en-3,17-dione).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_10">
            <num>(10)</num>
            <content>
              <p>5-androstenedione (androst-5-en-3,17-dione).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_11">
            <num>(11)</num>
            <content>
              <p>Bolasterone (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyandrost-\n4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_12">
            <num>(12)</num>
            <content>
              <p>Boldenone (17{beta}-hydroxyandrost-1, 4,-diene-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_13">
            <num>(13)</num>
            <content>
              <p>Boldione (androsta-1,4-diene-3,17-dione).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_14">
            <num>(14)</num>
            <content>
              <p>Calusterone (7{beta}, 17{alpha}-dimethyl-17{beta}-hydroxyandrost-\n4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_15">
            <num>(15)</num>
            <content>
              <p>Clostebol (4-chloro-17{beta}-hydroxyandrost-4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_16">
            <num>(16)</num>
            <content>
              <p>Dehydrochloromethyltestosterone (4-chloro-17{beta}-hydroxy-17\n{alpha}-methyl-androst-1, 4-dien-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_17">
            <num>(17)</num>
            <content>
              <p>{Delta} 1-dihydrotestosterone (a.k.a. '1-testosterone') (17\n{beta}-hydroxy-5{alpha}-androst-1-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_18">
            <num>(18)</num>
            <content>
              <p>4-dihydrotestosterone (17{beta}-hydroxy-androstan-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_19">
            <num>(19)</num>
            <content>
              <p>Drostanolone (17{beta}-hydroxy-2{alpha}-methyl-5{alpha}\n-androstan-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_20">
            <num>(20)</num>
            <content>
              <p>Ethylestrenol (17{alpha}-ethyl-17{beta}-hydroxyestr- 4-ene).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_21">
            <num>(21)</num>
            <content>
              <p>Fluoxymesterone (9-fluoro-17{alpha}-methyl-11{beta}, 17 {beta}-\ndihydroxyandrost-4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_22">
            <num>(22)</num>
            <content>
              <p>Formebolone (2-formyl-17{alpha}-methyl-11{alpha},\n17{beta}-dihydroxyandrost-1, 4-dien-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_23">
            <num>(23)</num>
            <content>
              <p>Furazabol (17{alpha}-methyl-17{beta}-hydroxyandrostano\n{2, 3-c}-furazan).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_24">
            <num>(24)</num>
            <content>
              <p>13{beta}-ethyl-17{beta}-hyroxygon-4-en-3-one.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_25">
            <num>(25)</num>
            <content>
              <p>4-hydroxytestosterone (4, 17{beta}-dihydroxy-androst-4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_26">
            <num>(26)</num>
            <content>
              <p>4-hydroxy-19-nortestosterone\n(4,17{beta}-dihydroxy-estr-4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_27">
            <num>(27)</num>
            <content>
              <p>desoxymethyltestosterone\n(17{alpha}-methyl-5{alpha}-androst-2-en-17{beta}-ol) (a.k.a., madol).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_28">
            <num>(28)</num>
            <content>
              <p>Mestanolone  (17{alpha}-methyl-17{beta}-hydroxy-\n5-androstan-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_29">
            <num>(29)</num>
            <content>
              <p>Mesterolone (1{alpha} methyl-17{beta}-hydroxy-\n{5{alpha}}-androstan-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_30">
            <num>(30)</num>
            <content>
              <p>Methandienone (17{alpha}-methyl-17{beta}-hydroxyandrost-1,\n4-dien-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_31">
            <num>(31)</num>
            <content>
              <p>Methandriol (17{alpha}-methyl-3{beta},\n17{beta}-dihydroxyandrost-5-ene).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_32">
            <num>(32)</num>
            <content>
              <p>Methenolone (1-methyl-17{beta}-hydroxy-5{alpha}-androst-\n1-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_33">
            <num>(33)</num>
            <content>
              <p>17{alpha}-methyl-3{beta},17{beta}-dihydroxy-5a-androstane.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_34">
            <num>(34)</num>
            <content>
              <p>17{alpha}-methyl-3{alpha}, 17{beta}-dihydroxy- 5a-androstane.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_35">
            <num>(35)</num>
            <content>
              <p>17{alpha}-methyl-3{beta}, 17{beta}-dihydroxyandrost-4-ene.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_36">
            <num>(36)</num>
            <content>
              <p>17{alpha}-methyl-4-hydroxynandrolone (17{alpha}-methyl-4-\nhydroxy-17{beta}-hydroxyestr-4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_37">
            <num>(37)</num>
            <content>
              <p>Methyldienolone (17{alpha}-methyl-17{beta}-hydroxyestra-\n4,9</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_10">
            <num>(10)</num>
            <content>
              <p>-dien-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_38">
            <num>(38)</num>
            <content>
              <p>Methyltrienolone (17{alpha}-methyl-17{beta}-hydroxyestra-4,\n9-11-trien-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_39">
            <num>(39)</num>
            <content>
              <p>Methyltestosterone (17{alpha}-methyl-17{beta}-hydroxyandrost-\n4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_40">
            <num>(40)</num>
            <content>
              <p>Mibolerone (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyestr-\n4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_41">
            <num>(41)</num>
            <content>
              <p>17{alpha}-methyl-{Delta} 1-dihydrotestosterone\n(17b{beta}-hydroxy-17{alpha}-methyl-5{alpha}-androst-1-en-3-one)\n(a.k.a. '17-{alpha}-methyl-1-testosterone').\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_42">
            <num>(42)</num>
            <content>
              <p>Nandrolone(17{beta}-hydroxyestr-4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_43">
            <num>(43)</num>
            <content>
              <p>19-nor-4-androstenediol (3{beta},17{beta}-dihydroxyestr -4-ene).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_44">
            <num>(44)</num>
            <content>
              <p>19-nor-4-androstenediol (3{alpha},17{beta}-dihydroxyestr-4-ene).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_45">
            <num>(45)</num>
            <content>
              <p>19-nor-5-androstenediol (3{beta},17{beta}-dihydroxyestr -5-ene).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_46">
            <num>(46)</num>
            <content>
              <p>19-nor-5-androstenediol (3{alpha},17{beta}-dihydroxyestr-5-ene).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_47">
            <num>(47)</num>
            <content>
              <p>19-nor-4,9</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_10">
            <num>(10)</num>
            <content>
              <p>-androstadienedione\n(estra-4,9</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_10">
            <num>(10)</num>
            <content>
              <p>-diene-3,17-dione).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_48">
            <num>(48)</num>
            <content>
              <p>19-nor-4-androstenedione (estr-4-en-3,17-dione).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_49">
            <num>(49)</num>
            <content>
              <p>19-nor-5-androstenedione (estr-5-en-3,17-dione).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_50">
            <num>(50)</num>
            <content>
              <p>Norbolethone (13{beta}, 17{alpha}-diethyl-17{beta}\n-hydroxygon-4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_51">
            <num>(51)</num>
            <content>
              <p>Norclostebol (4-chloro-17{beta}-hydroxyestr-4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_52">
            <num>(52)</num>
            <content>
              <p>Norethandrolone (17{alpha}-ethyl-17{beta}-hydroxyestr-\n4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_53">
            <num>(53)</num>
            <content>
              <p>Normethandrolone (17{alpha}-methyl-17{beta}\n-hydroxyestr-4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_54">
            <num>(54)</num>
            <content>
              <p>Oxandrolone (17{alpha}-methyl-17{beta}-hydroxy-2-oxa-\n{5{alpha}}-androstan-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_55">
            <num>(55)</num>
            <content>
              <p>Oxymesterone (17{alpha}-methyl-4, 17{beta}-dihydroxy\nandrost-4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_56">
            <num>(56)</num>
            <content>
              <p>Oxymetholone (17 {alpha}-methyl-2-hydroxymethylene-17\n{beta}-hydroxy-{5{alpha}}- androstan-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_57">
            <num>(57)</num>
            <content>
              <p>Stanozolol (17{alpha}-methyl-17{beta}-hydroxy-{5{alpha}}-\nandrost-2-eno{3, 2-c}-pyrazole).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_58">
            <num>(58)</num>
            <content>
              <p>Stenbolone (17{beta}-hydroxy-2-methyl-{5{alpha}}-androst-\n1-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_59">
            <num>(59)</num>
            <content>
              <p>Testolactone (13-hydroxy-3-oxo-13, 17-secoandrosta-1,\n4-dien-17-oic acid lactone).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_60">
            <num>(60)</num>
            <content>
              <p>Testosterone (17{beta}-hydroxyandrost-4-en-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_61">
            <num>(61)</num>
            <content>
              <p>Tetrahydrogestrinone (13{beta}, 17{alpha}-diethyl\n-17{beta}-hydroxygon-4, 9, 11-trien-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_62">
            <num>(62)</num>
            <content>
              <p>Trenbolone (17{beta}-hydroxyestr-4, 9, 11-trien-3-one).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_h__subsec_63">
            <num>(63)</num>
            <content>
              <p>Any salt, ester or ether of a drug or substance described or\nlisted in this subdivision.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_i">
          <num>(i)</num>
          <content>
            <p>Subdivision</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_h">
          <num>(h)</num>
          <content>
            <p>of this section shall not include any substance\ncontaining anabolic steroids expressly intended for administration\nthrough implants to cattle or other nonhuman species and that are\napproved by the federal food and drug administration solely for such\nuse.  Any individual who knowingly and willfully administers to himself\nor another person, prescribes, dispenses or distributes such substances\nfor other than implantation to cattle or nonhuman species shall be\nsubject to the same penalties as a practitioner who violates the\nprovisions of this section or any other penalties prescribed by law.\n  Schedule III.</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_a">
          <num>(a)</num>
          <content>
            <p>Schedule III shall consist of the drugs and other\nsubstances, by whatever official name, common or usual name, chemical\nname, or brand name designated, listed in this section.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_b">
          <num>(b)</num>
          <content>
            <p>Stimulants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a stimulant\neffect on the central nervous system, including its salts, isomers\n(whether optical, position, or geometric), and salts of such isomers\nwhenever the existence of such salts, isomers, and salts of isomers is\npossible within the specific chemical designation:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_b__subsec_1">
            <num>(1)</num>
            <content>
              <p>Those compounds, mixtures, or preparations in dosage unit form\ncontaining any stimulant substances listed in schedule II which\ncompounds, mixtures, or preparations were listed on August twenty-five,\nnineteen hundred seventy-one, as excepted compounds under title\ntwenty-one, section 308.32 of the code of federal regulations and any\nother drug of the quantitive composition shown in that list for those\ndrugs or which is the same except that it contains a lesser quantity of\ncontrolled substances.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_2">
            <num>(2)</num>
            <content>
              <p>Benzphetamine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_3">
            <num>(3)</num>
            <content>
              <p>Chlorphentermine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_4">
            <num>(4)</num>
            <content>
              <p>Clortermine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_6">
            <num>(6)</num>
            <content>
              <p>Phendimetrazine.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_c">
          <num>(c)</num>
          <content>
            <p>Depressants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a depressant\neffect on the central nervous system, including its salts, isomers, and\nsalts of isomers:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_c__subsec_1">
            <num>(1)</num>
            <content>
              <p>Any compound, mixture or preparation containing:\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_i">
          <num>(i)</num>
          <content>
            <p>Amobarbital;\n  (ii) Secobarbital;\n  (iii) Pentobarbital;\nor any salt thereof and one or more other active medicinal ingredients\nwhich are not listed in any schedule.\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_i__subsec_2">
            <num>(2)</num>
            <content>
              <p>Any suppository dosage form containing:\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_i">
          <num>(i)</num>
          <content>
            <p>Amobarbital;\n  (ii) Secobarbital;\n  (iii) Pentobarbital;\nor any salt of any of these drugs and approved by the federal food and\ndrug administration for marketing only as a suppository.\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_i__subsec_3">
            <num>(3)</num>
            <content>
              <p>Any substance which contains any quantity of a derivative of\nbarbituric acid or any salt thereof.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_i__subsec_4">
            <num>(4)</num>
            <content>
              <p>Chlorhexadol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_i__subsec_5">
            <num>(5)</num>
            <content>
              <p>Lysergic acid.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_i__subsec_6">
            <num>(6)</num>
            <content>
              <p>Lysergic acid amide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_i__subsec_7">
            <num>(7)</num>
            <content>
              <p>Methyprylon.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_i__subsec_8">
            <num>(8)</num>
            <content>
              <p>Sulfondiethylmethane.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_i__subsec_9">
            <num>(9)</num>
            <content>
              <p>Sulfonethylmethane.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_i__subsec_10">
            <num>(10)</num>
            <content>
              <p>Sulfonmethane.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_i__subsec_11">
            <num>(11)</num>
            <content>
              <p>Tiletamine and zolazepam or any salt thereof. Some trade or other\nnames for a tiletamine-zolazepam combination product: Telazol.  Some\ntrade or other names for tiletamine: 2-(ethylamino) -2-(2-thienyl)\n-cyclohexanone. Some trade or other names for zolazepam:\n4-(2-fluorophenyl) -6,8-dihydro -1, 3, 8i-trimethylpyrazolo-{3,4-e}\n{1,4} -diazepin-7(1H)-one, flupyrazapon.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_i__subsec_12">
            <num>(12)</num>
            <content>
              <p>Gamma hydroxybutyric acid, and salt, hydroxybutyric compound,\nderivative or preparation of gamma hydroxybutyric acid, including any\nisomers, esters and ethers and salts of isomers, esters and ethers of\ngamma hydroxybutyric acid, contained in a drug product for which an\napplication has been approved under section 505 of the federal food,\ndrug and cosmetic act.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_i__subsec_13">
            <num>(13)</num>
            <content>
              <p>Ketamine,  its  salts,  isomers  and salts  of  isomers  (some\nother  names  for  ketamine:  ()-2-(2-chlorophenyl)-2-(methylamino)-\ncyclohexanone).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_i__subsec_14">
            <num>(14)</num>
            <content>
              <p>Embutramide.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_d">
          <num>(d)</num>
          <content>
            <p>Nalorphine.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_e">
          <num>(e)</num>
          <content>
            <p>Narcotic drugs. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation\ncontaining any of the following narcotic drugs, or their salts\ncalculated as the free anhydrous base or alkaloid, in limited quantities\nas set forth below:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_e__subsec_1">
            <num>(1)</num>
            <content>
              <p>Not more than 1.8 grams of codeine per one hundred milliliters or\nnot more than ninety milligrams per dosage unit, with an equal or\ngreater quantity of an isoquinoline alkaloid of opium.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_2">
            <num>(2)</num>
            <content>
              <p>Not more than 1.8 grams of codeine per one hundred milliliters or\nnot more than ninety milligrams per dosage unit, with one or more\nactive, nonnarcotic ingredients in recognized therapeutic amounts.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_3">
            <num>(3)</num>
            <content>
              <p>Not more than 1.8 grams of dihydrocodeine per one hundred\nmilliliters or not more than ninety milligrams per dosage unit, with one\nor more active nonnarcotic ingredients in recognized therapeutic\namounts.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_4">
            <num>(4)</num>
            <content>
              <p>Not more than three hundred milligrams of ethylmorphine per one\nhundred milliliters or not more than fifteen milligrams per dosage unit,\nwith one or more active, nonnarcotic ingredients in recognized\ntherapeutic amounts.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_5">
            <num>(5)</num>
            <content>
              <p>Not more than five hundred milligrams of opium per one hundred\nmilliliters or per one hundred grams or not more than twenty-five\nmilligrams per dosage unit, with one or more active, nonnarcotic\ningredients in recognized therapeutic amounts.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_6">
            <num>(6)</num>
            <content>
              <p>Not more than fifty milligrams of morphine per one hundred\nmilliliters or per one hundred grams, with one or more active,\nnonnarcotic ingredients in recognized therapeutic amounts.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_7">
            <num>(7)</num>
            <content>
              <p>Buprenorphine in any quantities.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_f">
          <num>(f)</num>
          <content>
            <p>Dronabinol (synthetic) in sesame oil and encapsulated in a soft\ngelatin capsule in a U.S. Food and Drug Administration approved product.\n  Some other names for dronabinol include: (6aR-trans)-6a, 7, 8,\n10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo{b,d} pyran-1-o1, or\n(-)-delta-9-(trans) - tetrahydrocannabinol.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_g">
          <num>(g)</num>
          <content>
            <p>Chorionic gonadotropin.</p>
          </content>
          <paragraph eId="sec_3306__subsec_g__subsec_1">
            <num>(1)</num>
            <content>
              <p>Unless specifically excepted or unless\nlisted in another schedule any material, compound, mixture, or\npreparation which contains any amount of chorionic gonadotropin.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_g__subsec_2">
            <num>(2)</num>
            <content>
              <p>Paragraph one of this subdivision shall not include any substance\ncontaining chorionic gonadotropin expressly intended for administration\nthrough implants or injection to cattle or other nonhuman species and\nthat are approved by the federal food and drug administration solely for\nsuch use. Any individual who knowingly and willfully administers to\nhimself or another person, prescribes, dispenses or distributes such\nsubstances for other than implantation or injection to cattle or\nnonhuman species shall be subject to the same penalties as a\npractitioner who violates the provisions of this section or any other\npenalties prescribed by law.\n  Schedule IV.</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_a">
          <num>(a)</num>
          <content>
            <p>Schedule IV shall consist of the drugs and other\nsubstances, by whatever official name, common or usual name, chemical\nname, or brand name designated, listed in this section.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_b">
          <num>(b)</num>
          <content>
            <p>Narcotic drugs. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation\ncontaining any of the following narcotic drugs, or their salts\ncalculated as the free anhydrous base or alkaloid, in limited quantities\nas set forth below:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_b__subsec_1">
            <num>(1)</num>
            <content>
              <p>Not more than one milligram of difenoxin and not less than\ntwenty-five micrograms of atropine sulfate per dosage unit.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_2">
            <num>(2)</num>
            <content>
              <p>Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-\nmethyl-2-propionoxybutane).\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_c">
          <num>(c)</num>
          <content>
            <p>Depressants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances, including its salts,\nisomers, and salts of isomers whenever the existence of such salts,\nisomers, and salts of isomers is possible within the specific chemical\ndesignation:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_c__subsec_1">
            <num>(1)</num>
            <content>
              <p>Alprazolam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_2">
            <num>(2)</num>
            <content>
              <p>Barbital.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_3">
            <num>(3)</num>
            <content>
              <p>Bromazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_4">
            <num>(4)</num>
            <content>
              <p>Camazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_5">
            <num>(5)</num>
            <content>
              <p>Chloral betaine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_6">
            <num>(6)</num>
            <content>
              <p>Chloral hydrate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_7">
            <num>(7)</num>
            <content>
              <p>Chlordiazepoxide.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_8">
            <num>(8)</num>
            <content>
              <p>Clobazam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_9">
            <num>(9)</num>
            <content>
              <p>Clonazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_10">
            <num>(10)</num>
            <content>
              <p>Clorazepate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_11">
            <num>(11)</num>
            <content>
              <p>Clotiazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_12">
            <num>(12)</num>
            <content>
              <p>Cloxazolam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_13">
            <num>(13)</num>
            <content>
              <p>Delorazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_14">
            <num>(14)</num>
            <content>
              <p>Diazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_15">
            <num>(15)</num>
            <content>
              <p>Estazolam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_16">
            <num>(16)</num>
            <content>
              <p>Ethchlorvynol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_17">
            <num>(17)</num>
            <content>
              <p>Ethinamate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_18">
            <num>(18)</num>
            <content>
              <p>Ethyl Loflazepate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_19">
            <num>(19)</num>
            <content>
              <p>Fludiazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_20">
            <num>(20)</num>
            <content>
              <p>Flunitrazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_21">
            <num>(21)</num>
            <content>
              <p>Flurazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_22">
            <num>(22)</num>
            <content>
              <p>Halazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_23">
            <num>(23)</num>
            <content>
              <p>Haloxazolam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_24">
            <num>(24)</num>
            <content>
              <p>Ketazolam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_25">
            <num>(25)</num>
            <content>
              <p>Loprazolam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_26">
            <num>(26)</num>
            <content>
              <p>Lorazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_27">
            <num>(27)</num>
            <content>
              <p>Lormetazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_28">
            <num>(28)</num>
            <content>
              <p>Mebutamate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_29">
            <num>(29)</num>
            <content>
              <p>Medazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_30">
            <num>(30)</num>
            <content>
              <p>Meprobamate.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_31">
            <num>(31)</num>
            <content>
              <p>Methohexital.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_32">
            <num>(32)</num>
            <content>
              <p>Methylphenobarbital (mephobarbital).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_33">
            <num>(33)</num>
            <content>
              <p>Nimetazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_34">
            <num>(34)</num>
            <content>
              <p>Nitrazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_35">
            <num>(35)</num>
            <content>
              <p>Nordiazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_36">
            <num>(36)</num>
            <content>
              <p>Oxazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_37">
            <num>(37)</num>
            <content>
              <p>Oxazolam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_38">
            <num>(38)</num>
            <content>
              <p>Paraldehyde.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_39">
            <num>(39)</num>
            <content>
              <p>Petrichoral.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_40">
            <num>(40)</num>
            <content>
              <p>Phenobarbital.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_41">
            <num>(41)</num>
            <content>
              <p>Pinazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_42">
            <num>(42)</num>
            <content>
              <p>Prazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_43">
            <num>(43)</num>
            <content>
              <p>Temazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_44">
            <num>(44)</num>
            <content>
              <p>Tetrazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_45">
            <num>(45)</num>
            <content>
              <p>Triazolam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_46">
            <num>(46)</num>
            <content>
              <p>Midazolam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_47">
            <num>(47)</num>
            <content>
              <p>Quazepam.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_48">
            <num>(48)</num>
            <content>
              <p>Zolpidem.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_49">
            <num>(49)</num>
            <content>
              <p>Dichloralphenazone.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_50">
            <num>(50)</num>
            <content>
              <p>Zaleplon.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_51">
            <num>(51)</num>
            <content>
              <p>Zopiclone (eszopiclone).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_52">
            <num>(52)</num>
            <content>
              <p>Fospropofol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_c__subsec_53">
            <num>(53)</num>
            <content>
              <p>Carisoprodol.\n  *</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_d">
          <num>(d)</num>
          <content>
            <p>Fenfluramine. Any material, compound, mixture, or preparation\nwhich contains any quantity of the following substances, including its\nsalts, isomers (whether optical, position, or geometric), and salts of\nsuch isomers, whenever the existence of such salts, isomers and salts of\nisomers is possible:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_d__subsec_1">
            <num>(1)</num>
            <content>
              <p>Fenfluramine.\n  * NB Repealed upon the removal of fenfluramine and its salts and\nisomers from Schedule IV of the federal Controlled Substances Act\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_e">
          <num>(e)</num>
          <content>
            <p>Stimulants. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture, or preparation which\ncontains any quantity of the following substances having a stimulant\neffect on the central nervous system, including its salts, isomers, and\nsalts of such isomers:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_e__subsec_1">
            <num>(1)</num>
            <content>
              <p>Cathine ((+) - norpseudoephedrine).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_2">
            <num>(2)</num>
            <content>
              <p>Diethylpropion.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_3">
            <num>(3)</num>
            <content>
              <p>Fencamfamin.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_4">
            <num>(4)</num>
            <content>
              <p>Fenproporex.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_5">
            <num>(5)</num>
            <content>
              <p>Mazindol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_6">
            <num>(6)</num>
            <content>
              <p>Mefenorex.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_7">
            <num>(7)</num>
            <content>
              <p>Pemoline (including organometallic complexes and chelates\nthereof).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_8">
            <num>(8)</num>
            <content>
              <p>Phentermine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_9">
            <num>(9)</num>
            <content>
              <p>Pipradrol.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_10">
            <num>(10)</num>
            <content>
              <p>SPA((-))-1-dimethylamino-1, 2-diphenylethane).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_11">
            <num>(11)</num>
            <content>
              <p>Modafinil.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_e__subsec_12">
            <num>(12)</num>
            <content>
              <p>Sibutramine.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_f">
          <num>(f)</num>
          <content>
            <p>Other substances. Unless specifically excepted or unless listed in\nanother schedule, any material, compound, mixture or preparation which\ncontains any quantity of the following substances, including its salts:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_f__subsec_1">
            <num>(1)</num>
            <content>
              <p>Pentazocine.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_2">
            <num>(2)</num>
            <content>
              <p>Butorphanol (including its optical isomers).\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_f__subsec_3">
            <num>(3)</num>
            <content>
              <p>Tramadol in any quantities.\n  Schedule V.</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_a">
          <num>(a)</num>
          <content>
            <p>Schedule V shall consist of the drugs and other\nsubstances, by whatever official name, common or usual name, chemical\nname, or brand name designated, listed in this section.\n</p>
          </content>
        </subsection>
        <subsection eId="sec_3306__subsec_b">
          <num>(b)</num>
          <content>
            <p>Narcotic drugs containing nonnarcotic active medicinal\ningredients.  Any compound, mixture, or preparation containing any of\nthe following narcotic drugs, or their salts calculated as the free\nanhydrous base or alkaloid, in limited quantities as set forth below,\nwhich shall include one or more nonnarcotic active medicinal ingredients\nin sufficient proportion to confer upon the compound, mixture, or\npreparation valuable medicinal qualities other than those possessed by\nnarcotic drugs alone:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_b__subsec_1">
            <num>(1)</num>
            <content>
              <p>Not more than two hundred milligrams of codeine per one hundred\nmilliliters or per one hundred grams.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_2">
            <num>(2)</num>
            <content>
              <p>Not more than one hundred milligrams of dihydrocodeine per one\nhundred milliliters or per one hundred grams.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_3">
            <num>(3)</num>
            <content>
              <p>Not more than one hundred milligrams of ethylmorphine per one\nhundred milliliters or per one hundred grams.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_4">
            <num>(4)</num>
            <content>
              <p>Not more than 2.5 milligrams of diphenoxylate and not less than\ntwenty-five micrograms of atropine sulfate per dosage unit.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_5">
            <num>(5)</num>
            <content>
              <p>Not more than one hundred milligrams of opium per one hundred\nmilliliters or per one hundred grams.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_b__subsec_6">
            <num>(6)</num>
            <content>
              <p>Not more than 0.5 milligram of difenoxin and not less than\ntwenty-five micrograms of atropine sulfate per dosage unit.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_c">
          <num>(c)</num>
          <content>
            <p>Stimulants. Unless specifically exempted or excluded or unless\nlisted in another schedule, any material, compound, mixture, or\npreparation which contains any quantity of the following substances\nhaving a stimulant effect on the central nervous system, including its\nsalts, isomers and salts of isomers:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_c__subsec_1">
            <num>(1)</num>
            <content>
              <p>Pyrovalerone.\n</p>
            </content>
          </paragraph>
        </subsection>
        <subsection eId="sec_3306__subsec_d">
          <num>(d)</num>
          <content>
            <p>Depressants. Unless specifically exempted or excluded or unless\nlisted in another schedule, any material, compound, mixture, or\npreparation which contains any quantity of the following substances\nhaving a depressant effect on the central nervous system, including its\nsalts, isomers, and salts of isomers:\n</p>
          </content>
          <paragraph eId="sec_3306__subsec_d__subsec_1">
            <num>(1)</num>
            <content>
              <p>Ezogabine {N-{2-amino-4-(4-fluorobenzylamino)-phenyl}-carbamic\nacid ethyl ester}.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_2">
            <num>(2)</num>
            <content>
              <p>Lacosamide {(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide}.\n</p>
            </content>
          </paragraph>
          <paragraph eId="sec_3306__subsec_d__subsec_3">
            <num>(3)</num>
            <content>
              <p>Pregabalin {(S)-3-(aminomethyl)-5-methylhexanoic acid }.\n</p>
            </content>
          </paragraph>
        </subsection>
      </section>
    </body>
  </act>
</akomaNtoso>